Reply to Roesler et al. Comment on “Karaulic et al. Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment. Cancers 2025, 17, 3659”
Cancers · 02.03.2026 · 18 (5) · 803
DOI: 10.3390/cancers18050803 ↗Kurz gefasst
Kommentar in der Zeitschrift Cancers, online erschienen am 02.03.2026. Verfasst von Arthur Karaulic und 2 weiteren Autor:innen. Beteiligte Einrichtung: University Côte d'Azur, Institute for Research on Cancer and Ageing of Nice (IRCAN, UMR CNRS 7284/U INSERM 1081), 06100 Nice, France. Die Arbeit nennt 4 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We gratefully thank R [...]
Autor:innen und Institutionen
- University Côte d'Azur, Institute for Research on Cancer and Ageing of Nice (IRCAN, UMR CNRS 7284/U INSERM 1081), 06100 Nice, France.
ORCID-Profile: Arthur Karaulic, Gilles Pagès
Zitieren
APA
Karaulic, A., Fournier, C., & Pagès, G. (2026). Reply to Roesler et al. Comment on “Karaulic et al. Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment. Cancers 2025, 17, 3659”. Cancers, 18(5), 803. https://doi.org/10.3390/cancers18050803
Vancouver
Karaulic A, Fournier C, Pagès G. Reply to Roesler et al. Comment on “Karaulic et al. Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment. Cancers 2025, 17, 3659”. Cancers. 2026;18(5):803. doi:10.3390/cancers18050803
BibTeX
@article{Karaulic2026,
author = {Karaulic, Arthur and Fournier, Clémence and Pagès, Gilles},
title = {Reply to Roesler et al. Comment on “Karaulic et al. Exploring Novel Applications: Repositioning Clinically Approved Therapies for Medulloblastoma Treatment. Cancers 2025, 17, 3659”},
journal = {Cancers},
year = {2026},
volume = {18},
number = {5},
pages = {803},
doi = {10.3390/cancers18050803}
}
EUVIMED